What are the major opportunities in the bipolar disorder therapeutics market? What are the strategies for the bipolar disorder therapeutics market?

For detailed insights on the major opportunities and strategies in the bipolar disorder therapeutics market, Read More

How does the bipolar disorder therapeutics market relate to the overall economy and other similar markets?

For detailed insights on bipolar disorder therapeutics market's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the bipolar disorder therapeutics market growth? SWOT analysis of the bipolar disorder therapeutics market.

For detailed insights on the key dynamics influencing the bipolar disorder therapeutics market growth and SWOT analysis of the bipolar disorder therapeutics industry, Read More

Bipolar Disorder Therapeutics Market Global Report 2026 Market Report Infographic Image

Item added to cart!

Published : February 2026

Pages : 200

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF

Purchase This Report

Bipolar Disorder Therapeutics Market Report 2026

Name: Bipolar Disorder Therapeutics Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Drug Class (Mood Stabilizers, Antipsychotic Drugs, Antidepressant Drugs, Other Drugs), By Mechanism (Selective Serotonin Reuptake Inhibitors, Serotonin-norepinephrine Reuptake Inhibitors, Tricyclic Antidepressants, Monoamine Oxidase Inhibitors, Benzodiazepines, Other Mechanisms), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Bipolar Disorder Therapeutics Market Overview

• Bipolar Disorder Therapeutics market size has reached to $7.82 billion in 2025

• Expected to grow to $10.39 billion in 2030 at a compound annual growth rate (CAGR) of 5.9%

• Growth Driver: A Lifelong Condition That Requires Early Diagnosis And Proper Treatment

• Market Trend: The Rise Of Novel Therapies For Bipolar Disorders

• North America was the largest region in 2025 and Europe is the fastest growing region.

What Is Covered Under Bipolar Disorder Therapeutics Market?

Bipolar disorder therapeutics refer to medication, including mood stabilizers, antidepressants, antipsychotics, and psychological counseling, to control symptoms. The bipolar disorder therapeutic is used in the treatment and management of bipolar disorders.

The main types of drugs in bipolar disorder therapeutics are mood stabilizers, antipsychotic drugs, antidepressant drugs, and other drugs. Mood stabilizers refer to a class of medications used in the management and treatment of bipolar disorders. The different mechanisms include selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, tricyclic antidepressants, monoamine oxidase inhibitors, benzodiazepines, beta-blockers, and others. These are distributed through hospital pharmacies, retail pharmacies, and online pharmacies.

Bipolar Disorder Therapeutics Market Global Report 2026 Market Report bar graph

What Is The Bipolar Disorder Therapeutics Market Size and Share 2026?

The bipolar disorder therapeutics market size has grown strongly in recent years. It will grow from $7.82 billion in 2025 to $8.28 billion in 2026 at a compound annual growth rate (CAGR) of 5.9%. The growth in the historic period can be attributed to increasing diagnosis of bipolar disorder, growing awareness of mental health conditions, expansion of psychiatric care services, availability of established pharmacological treatments, rising healthcare expenditure.

What Is The Bipolar Disorder Therapeutics Market Growth Forecast?

The bipolar disorder therapeutics market size is expected to see strong growth in the next few years. It will grow to $10.39 billion in 2030 at a compound annual growth rate (CAGR) of 5.9%. The growth in the forecast period can be attributed to increasing demand for precision psychiatry solutions, expansion of long-acting injectable therapies, growing integration of digital therapeutics, rising focus on treatment adherence improvement, increasing investment in mental health research. Major trends in the forecast period include increasing development of novel mood stabilizing therapies, rising adoption of atypical antipsychotic medications, growing focus on personalized mental health treatment, expansion of combination drug therapies, enhanced integration of digital mental health support.

Book your 30 minutes free consultation with our research experts

Global Bipolar Disorder Therapeutics Market Segmentation

1) By Drug Class: Mood Stabilizers, Antipsychotic Drugs, Antidepressant Drugs, Other Drugs

2) By Mechanism: Selective Serotonin Reuptake Inhibitors, Serotonin-norepinephrine Reuptake Inhibitors, Tricyclic Antidepressants, Monoamine Oxidase Inhibitors, Benzodiazepines, Other Mechanisms

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Mood Stabilizers: Lithium, Anticonvulsants

2) By Antipsychotic Drugs: Atypical Antipsychotics, Typical Antipsychotics

3) By Antidepressant Drugs: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs), Tricyclic Antidepressants (TCAs)

4) By Other Drugs: Benzodiazepines, Adjunctive Therapies

What Is The Driver Of The Bipolar Disorder Therapeutics Market?

The increasing healthcare expenditure is expected to propel the growth of the bipolar disorder therapeutics market going forward. Healthcare infrastructure refers to all costs or outlays for medical care, preventative measures, public health initiatives, rehabilitation, community health activities, and health research. Increasing healthcare expenditure can be attributed to several factors, including an aging population, a rise in chronic diseases, and higher drug costs, all of which significantly contribute to the growing demand for medical services and treatments. As awareness of mental health issues rises, the diagnosis of bipolar disorder increases, leading to a higher demand for therapeutic interventions. For instance, in November 2023, according to the Canadian Institute for Health Information, a Canada-based non-profit organization, total health spending in Canada is anticipated to rise by 2.8% in 2023, following a modest growth of just 1.5% in 2022. Therefore, the increasing healthcare expenditure is driving the growth of the bipolar disorder therapeutics industry.

Key Players In The Global Bipolar Disorder Therapeutics Market

Major companies operating in the bipolar disorder therapeutics market are AbbVie Inc., Pfizer Inc., Astellas Pharma Inc., AstraZeneca PLC, Bristol-Myers Squibb, GlaxoSmithKline PLC, Janssen Pharmaceuticals, Novartis AG, Otsuka Pharmaceutical Co. Ltd., Eli Lilly and Company, Gedeon Richter PLC, Sumitomo Pharma Co. Ltd., H. Lundbeck A/S, Sanofi S.A., Allergan plc, Takeda Pharmaceutical Company Limited, Sunovion Pharmaceuticals Inc., Alkermes plc, Mylan N.V., Teva Pharmaceutical Industries Ltd., Johnson & Johnson, NeuroRx Inc., IntraCellular Therapies Inc., Vanda Pharmaceuticals Inc., Sage Therapeutics Inc.

Global Bipolar Disorder Therapeutics Market Trends and Insights

Major companies operating in the Bipolar Disorder Therapeutics and related market are developing new treatment for depressive episodes associated with bipolar I or II disorder to meet larger customer bases, more sales, and increase revenue. Among bipolar disorders, bipolar depression is the most prevalent and severe clinical manifestation. If compared to manic/hypomanic episodes, these depressed episodes are linked to a poorer prognosis, longer duration, and more recurrences. For instance, in March 2024, the EDIT-B consortium, a France-based collaborative organization that specializes in developing innovative diagnostic tools and biomarkers, launched myEDIT-B, an innovative blood diagnostic tool designed to provide objective biological data that aids psychiatrists and healthcare professionals in making precise diagnoses. It analyzes RNA editing-based biomarkers and has demonstrated sensitivity and specificity rates above 80%. By facilitating quicker and more accurate diagnoses potentially shortening the wait time to within four weeks myEDIT-B aims to tackle the significant issue of misdiagnosis in mental health, with around 40% of individuals diagnosed with depression possibly having bipolar disorder instead.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Bipolar Disorder Therapeutics Market?

In June 2023, Brain Therapeutics, a Greece-based central nervous system specialty company, acquired the prescription drug brand Lazap (olanzapine) from the Greek pharmaceutical company Lyofin Ltd for an undisclosed amount. The acquisition enables Neuraxpharm Group to expand its therapeutic product portfolio in Greece and Europe. This agreement aims to extend Neuraxpharm's reach in Greece and harness its deep expertise in the central nervous system (CNS) to offer the right products from its extensive lineup to CNS patients, healthcare professionals, pharmacists, and hospitals across Greece, effectively meeting the healthcare demands of patients in the country. Lyofin Ltd. is a Greece-based pharmaceutical company.

Regional Outlook

North America was the largest region in the bipolar disorder therapeutics market in 2025. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Bipolar Disorder Therapeutics Market?

The bipolar disorder therapeutics market includes revenues earned by entities by family-focused therapy, interpersonal and social rhythm therapy, cognitive behavioral therapy and dialectical behavior therapy. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Bipolar Disorder Therapeutics Market Report 2026?

The bipolar disorder therapeutics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the bipolar disorder therapeutics industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Bipolar Disorder Therapeutics Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$8.28 billion
Revenue Forecast In 2035	$10.39 billion
Growth Rate	CAGR of 5.9% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Drug Class, Mechanism, Distribution Channel
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	AbbVie Inc., Pfizer Inc., Astellas Pharma Inc., AstraZeneca PLC, Bristol-Myers Squibb, GlaxoSmithKline PLC, Janssen Pharmaceuticals, Novartis AG, Otsuka Pharmaceutical Co. Ltd., Eli Lilly and Company, Gedeon Richter PLC, Sumitomo Pharma Co. Ltd., H. Lundbeck A/S, Sanofi S.A., Allergan plc, Takeda Pharmaceutical Company Limited, Sunovion Pharmaceuticals Inc., Alkermes plc, Mylan N.V., Teva Pharmaceutical Industries Ltd., Johnson & Johnson, NeuroRx Inc., IntraCellular Therapies Inc., Vanda Pharmaceuticals Inc., Sage Therapeutics Inc.
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Bipolar Disorder Therapeutics Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Bipolar Disorder Therapeutics Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Bipolar Disorder Therapeutics Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Bipolar Disorder Therapeutics Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Digitalization, Cloud, Big Data & Cybersecurity

4.1.3 Artificial Intelligence & Autonomous Intelligence

4.1.4 Sustainability, Climate Tech & Circular Economy

4.1.5 Industry 4.0 & Intelligent Manufacturing

4.2. Major Trends

4.2.1 Increasing Development Of Novel Mood Stabilizing Therapies

4.2.2 Rising Adoption Of Atypical Antipsychotic Medications

4.2.3 Growing Focus On Personalized Mental Health Treatment

4.2.4 Expansion Of Combination Drug Therapies

4.2.5 Enhanced Integration Of Digital Mental Health Support

5. Bipolar Disorder Therapeutics Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Psychiatric Clinics

5.3 Specialty Mental Health Centers

5.4 Retail Pharmacies

5.5 Online Pharmacies

6. Bipolar Disorder Therapeutics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Bipolar Disorder Therapeutics Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Bipolar Disorder Therapeutics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Bipolar Disorder Therapeutics Market Size, Comparisons And Growth Rate Analysis

7.3. Global Bipolar Disorder Therapeutics Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Bipolar Disorder Therapeutics Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Bipolar Disorder Therapeutics Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Bipolar Disorder Therapeutics Market Segmentation

9.1. Global Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Mood Stabilizers, Antipsychotic Drugs, Antidepressant Drugs, Other Drugs

9.2. Global Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Selective Serotonin Reuptake Inhibitors, Serotonin-norepinephrine Reuptake Inhibitors, Tricyclic Antidepressants, Monoamine Oxidase Inhibitors, Benzodiazepines, Other Mechanisms

9.3. Global Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

9.4. Global Bipolar Disorder Therapeutics Market, Sub-Segmentation Of Mood Stabilizers, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Lithium, Anticonvulsants

9.5. Global Bipolar Disorder Therapeutics Market, Sub-Segmentation Of Antipsychotic Drugs, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Atypical Antipsychotics, Typical Antipsychotics

9.6. Global Bipolar Disorder Therapeutics Market, Sub-Segmentation Of Antidepressant Drugs, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs), Tricyclic Antidepressants (TCAs)

9.7. Global Bipolar Disorder Therapeutics Market, Sub-Segmentation Of Other Drugs, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Benzodiazepines, Adjunctive Therapies

10. Bipolar Disorder Therapeutics Market Regional And Country Analysis

10.1. Global Bipolar Disorder Therapeutics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Bipolar Disorder Therapeutics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Bipolar Disorder Therapeutics Market

11.1. Asia-Pacific Bipolar Disorder Therapeutics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Segmentation By Mechanism, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Bipolar Disorder Therapeutics Market

12.1. China Bipolar Disorder Therapeutics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Segmentation By Mechanism, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Bipolar Disorder Therapeutics Market

13.1. India Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Segmentation By Mechanism, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Bipolar Disorder Therapeutics Market

14.1. Japan Bipolar Disorder Therapeutics Market Overview

14.2. Japan Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Segmentation By Mechanism, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Bipolar Disorder Therapeutics Market

15.1. Australia Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Segmentation By Mechanism, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Bipolar Disorder Therapeutics Market

16.1. Indonesia Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Segmentation By Mechanism, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Bipolar Disorder Therapeutics Market

17.1. South Korea Bipolar Disorder Therapeutics Market Overview

17.2. South Korea Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Segmentation By Mechanism, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Bipolar Disorder Therapeutics Market

18.1. Taiwan Bipolar Disorder Therapeutics Market Overview

18.2. Taiwan Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Segmentation By Mechanism, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Bipolar Disorder Therapeutics Market

19.1. South East Asia Bipolar Disorder Therapeutics Market Overview

19.2. South East Asia Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Segmentation By Mechanism, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Bipolar Disorder Therapeutics Market

20.1. Western Europe Bipolar Disorder Therapeutics Market Overview

20.2. Western Europe Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Segmentation By Mechanism, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Bipolar Disorder Therapeutics Market

21.1. UK Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Segmentation By Mechanism, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Bipolar Disorder Therapeutics Market

22.1. Germany Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Segmentation By Mechanism, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Bipolar Disorder Therapeutics Market

23.1. France Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Segmentation By Mechanism, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Bipolar Disorder Therapeutics Market

24.1. Italy Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Segmentation By Mechanism, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Bipolar Disorder Therapeutics Market

25.1. Spain Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Segmentation By Mechanism, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Bipolar Disorder Therapeutics Market

26.1. Eastern Europe Bipolar Disorder Therapeutics Market Overview

26.2. Eastern Europe Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Segmentation By Mechanism, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Bipolar Disorder Therapeutics Market

27.1. Russia Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Segmentation By Mechanism, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Bipolar Disorder Therapeutics Market

28.1. North America Bipolar Disorder Therapeutics Market Overview

28.2. North America Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Segmentation By Mechanism, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Bipolar Disorder Therapeutics Market

29.1. USA Bipolar Disorder Therapeutics Market Overview

29.2. USA Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Segmentation By Mechanism, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Bipolar Disorder Therapeutics Market

30.1. Canada Bipolar Disorder Therapeutics Market Overview

30.2. Canada Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Segmentation By Mechanism, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Bipolar Disorder Therapeutics Market

31.1. South America Bipolar Disorder Therapeutics Market Overview

31.2. South America Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Segmentation By Mechanism, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Bipolar Disorder Therapeutics Market

32.1. Brazil Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Segmentation By Mechanism, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Bipolar Disorder Therapeutics Market

33.1. Middle East Bipolar Disorder Therapeutics Market Overview

33.2. Middle East Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Segmentation By Mechanism, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Bipolar Disorder Therapeutics Market

34.1. Africa Bipolar Disorder Therapeutics Market Overview

34.2. Africa Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Segmentation By Mechanism, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Bipolar Disorder Therapeutics Market Regulatory and Investment Landscape

36. Bipolar Disorder Therapeutics Market Competitive Landscape And Company Profiles

36.1. Bipolar Disorder Therapeutics Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Bipolar Disorder Therapeutics Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Bipolar Disorder Therapeutics Market Company Profiles

36.3.1. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Astellas Pharma Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.4. AstraZeneca PLC Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Bristol-Myers Squibb Overview, Products and Services, Strategy and Financial Analysis

37. Bipolar Disorder Therapeutics Market Other Major And Innovative Companies

GlaxoSmithKline PLC, Janssen Pharmaceuticals, Novartis AG, Otsuka Pharmaceutical Co. Ltd., Eli Lilly and Company, Gedeon Richter PLC, Sumitomo Pharma Co. Ltd., H. Lundbeck A/S, Sanofi S.A., Allergan plc, Takeda Pharmaceutical Company Limited, Sunovion Pharmaceuticals Inc., Alkermes plc, Mylan N.V., Teva Pharmaceutical Industries Ltd.

38. Global Bipolar Disorder Therapeutics Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Bipolar Disorder Therapeutics Market

40. Bipolar Disorder Therapeutics Market High Potential Countries, Segments and Strategies

40.1 Bipolar Disorder Therapeutics Market In 2030 - Countries Offering Most New Opportunities

40.2 Bipolar Disorder Therapeutics Market In 2030 - Segments Offering Most New Opportunities

40.3 Bipolar Disorder Therapeutics Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Bipolar Disorder Therapeutics Market, Overview Of Key Products - Product Examples

Table 2: Global Bipolar Disorder Therapeutics Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Bipolar Disorder Therapeutics Market, Supply Chain Analysis

Table 4: Global Bipolar Disorder Therapeutics Market, Major Raw Material Providers

Table 5: Global Bipolar Disorder Therapeutics Market, Major Resource Providers

Table 6: Global Bipolar Disorder Therapeutics Market, Major Manufacturers (Suppliers)

Table 7: Global Bipolar Disorder Therapeutics Market, Major Distributors And Channel Partners

Table 8: Global Bipolar Disorder Therapeutics Market, Key Technologies & Future Trends

Table 9: Global Bipolar Disorder Therapeutics Market, Major Trends

Table 10: Global Bipolar Disorder Therapeutics Market, Major End Users

Table 11: Global Bipolar Disorder Therapeutics Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Bipolar Disorder Therapeutics Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Bipolar Disorder Therapeutics Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Bipolar Disorder Therapeutics Market - TAM, US$ Billion, 2025

Table 15: Global Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Bipolar Disorder Therapeutics Market, Sub-Segmentation Of Mood Stabilizers, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Bipolar Disorder Therapeutics Market, Sub-Segmentation Of Antipsychotic Drugs, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Bipolar Disorder Therapeutics Market, Sub-Segmentation Of Antidepressant Drugs, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Bipolar Disorder Therapeutics Market, Sub-Segmentation Of Other Drugs, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global Bipolar Disorder Therapeutics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Global Bipolar Disorder Therapeutics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Asia-Pacific, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Asia-Pacific, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: Asia-Pacific, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: China, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: China, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: China, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: India, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: India, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: India, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: Japan, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: Japan, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Japan, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Australia, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Australia, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Australia, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Indonesia, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Indonesia, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: Indonesia, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: South Korea, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: South Korea, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: South Korea, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: Taiwan, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: Taiwan, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: Taiwan, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: South East Asia, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: South East Asia, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: South East Asia, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: Western Europe, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: Western Europe, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: Western Europe, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: UK, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: UK, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: UK, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: Germany, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: Germany, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: Germany, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: France, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: France, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: France, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: Italy, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: Italy, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Italy, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Spain, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Spain, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Spain, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Eastern Europe, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Eastern Europe, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Eastern Europe, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Russia, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Russia, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: Russia, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: North America, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: North America, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: North America, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: USA, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: USA, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: USA, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: Canada, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: Canada, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: Canada, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: South America, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: South America, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: South America, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: Brazil, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: Brazil, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Brazil, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Middle East, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Middle East, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Middle East, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Africa, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Africa, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Africa, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 96: Global Bipolar Disorder Therapeutics Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 97: Global Bipolar Disorder Therapeutics Market - Company Scoring Matrix

Table 98: AbbVie Inc. Financial Performance

Table 99: Pfizer Inc. Financial Performance

Table 100: Astellas Pharma Inc. Financial Performance

Table 101: AstraZeneca PLC Financial Performance

Table 102: Bristol-Myers Squibb Financial Performance

Table 103: Global Bipolar Disorder Therapeutics Market, Competitive Benchmarking (In USD Billions)

Table 104: Global Bipolar Disorder Therapeutics Market, Competitive Dashboard

Table 105: Global Bipolar Disorder Therapeutics Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 106: Global, Bipolar Disorder Therapeutics Market Size Gain ($ Billion), Segmentation By Drug Class, 2025 – 2030

Table 107: Global, Bipolar Disorder Therapeutics Market Size Gain ($ Billion), Segmentation By Mechanism, 2025 – 2030

Table 108: Global, Bipolar Disorder Therapeutics Market Size Gain ($ Billion), Segmentation By Distribution Channel, 2025 – 2030

List Of Figures

Figure 1: Global Bipolar Disorder Therapeutics Market, Overview Of Key Products - Product Examples

Figure 2: Global Bipolar Disorder Therapeutics Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Bipolar Disorder Therapeutics Market, Supply Chain Analysis

Figure 4: Global Bipolar Disorder Therapeutics Market, Major Raw Material Providers

Figure 5: Global Bipolar Disorder Therapeutics Market, Major Resource Providers

Figure 6: Global Bipolar Disorder Therapeutics Market, Major Manufacturers (Suppliers)

Figure 7: Global Bipolar Disorder Therapeutics Market, Major Distributors And Channel Partners

Figure 8: Global Bipolar Disorder Therapeutics Market, Key Technologies & Future Trends

Figure 9: Global Bipolar Disorder Therapeutics Market, Major Trends

Figure 10: Global Bipolar Disorder Therapeutics Market, Major End Users

Figure 11: Global Bipolar Disorder Therapeutics Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Bipolar Disorder Therapeutics Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Bipolar Disorder Therapeutics Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Bipolar Disorder Therapeutics Market - TAM, US$ Billion, 2025

Figure 15: Global Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Bipolar Disorder Therapeutics Market, Sub-Segmentation Of Mood Stabilizers, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Bipolar Disorder Therapeutics Market, Sub-Segmentation Of Antipsychotic Drugs, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Bipolar Disorder Therapeutics Market, Sub-Segmentation Of Antidepressant Drugs, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Bipolar Disorder Therapeutics Market, Sub-Segmentation Of Other Drugs, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global Bipolar Disorder Therapeutics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Global Bipolar Disorder Therapeutics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Asia-Pacific, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Asia-Pacific, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: Asia-Pacific, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: China, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: China, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: China, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: India, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: India, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: India, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: Japan, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: Japan, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Japan, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Australia, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Australia, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Australia, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Indonesia, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Indonesia, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: Indonesia, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: South Korea, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: South Korea, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: South Korea, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: Taiwan, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: Taiwan, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: Taiwan, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: South East Asia, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: South East Asia, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: South East Asia, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: Western Europe, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: Western Europe, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: Western Europe, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: UK, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: UK, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: UK, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: Germany, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: Germany, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: Germany, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: France, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: France, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: France, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: Italy, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: Italy, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Italy, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Spain, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Spain, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Spain, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Eastern Europe, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Eastern Europe, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Eastern Europe, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Russia, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Russia, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: Russia, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: North America, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: North America, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: North America, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: USA, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: USA, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: USA, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: Canada, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: Canada, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: Canada, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: South America, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: South America, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: South America, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: Brazil, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: Brazil, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Brazil, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Middle East, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Middle East, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Middle East, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Africa, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Africa, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Africa, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 96: Global Bipolar Disorder Therapeutics Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 97: Global Bipolar Disorder Therapeutics Market - Company Scoring Matrix

Figure 98: AbbVie Inc. Financial Performance

Figure 99: Pfizer Inc. Financial Performance

Figure 100: Astellas Pharma Inc. Financial Performance

Figure 101: AstraZeneca PLC Financial Performance

Figure 102: Bristol-Myers Squibb Financial Performance

Figure 103: Global Bipolar Disorder Therapeutics Market, Competitive Benchmarking (In USD Billions)

Figure 104: Global Bipolar Disorder Therapeutics Market, Competitive Dashboard

Figure 105: Global Bipolar Disorder Therapeutics Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 106: Global, Bipolar Disorder Therapeutics Market Size Gain ($ Billion), Segmentation By Drug Class, 2025 – 2030

Figure 107: Global, Bipolar Disorder Therapeutics Market Size Gain ($ Billion), Segmentation By Mechanism, 2025 – 2030

Figure 108: Global, Bipolar Disorder Therapeutics Market Size Gain ($ Billion), Segmentation By Distribution Channel, 2025 – 2030

Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

Explore future trends in the global pharma and biotech CRM software market. Understand market growth, drivers, and industry outlook through 2034.

Explore market drivers and forecast in the nasal spray influenza vaccine sector through 2025–2034.

Review key data-driven trends shaping the global data storage market in 2025.

Analyze the 6.7% CAGR growth trajectory and strategic trends shaping the global medical glass vaccine bottles market through 2029.

Mining Automation Market Report 2026 - Global Outlook – By Offering (Equipment, Software, Communication System), By Technique (Surface Mining, Underground Mining), By Workflow (Mine Development, Mining Process, Mine Main...

Nano UAV Market Report 2026 - Global Outlook – By Product Type (Fixed Wing, Rotary Wine, Other Products), By Propulsion System (Hydrogen Cell, Solar Cell, Lithium-Ion), By Application (Civil And Commercial, Military, Hom...

Baby Puffs and Snacks Market Report 2026 - Global Outlook – By Type (Snacks, Puffs), By Category (Organic, Conventional), By Sales Channel (Offline sales, Online sales) – Market Size, Trends, Strategies, and Forecast to ...

Artificial Intelligence Logo Generator Market Report 2026 - Global Outlook – By Component (Software, Services), By Deployment (Cloud-Based, On-Premises), By End-User (Media And Entertainment, Healthcare, Fashion, E-Comme...

Antidepressants Market Report 2026 - Global Outlook – By Product (Selective Serotonin Reuptake Inhibitor (SSRI), Serotonin-norepinephrine Reuptake Inhibitor (SNRI), Tricyclic Antidepressant (TCA), Monoamine Oxidase Inhib...

Servers Technology Market Report 2026 - Global Outlook – By Product (Blade, Micro, Open Compute Project, Rack, Tower), By Enterprise Size (Micro, Small, Medium, Large), By End User (Banking, Financial Services And Insura...

Vendor Risk Management Market Report 2026 - Global Outlook – By Component (Solution, Services), By Deployment Mode (Cloud, On-Premises), By Organization Size (Small And Medium-Sized Enterprises, Large Enterprises), By Ve...

Frequently Asked Questions

How big is the Bipolar Disorder Therapeutics Market?

The Bipolar Disorder Therapeutics market was valued at $7.82 billion in 2025, increased to $8.28 billion in 2026, and is projected to reach $10.39 billion by 2030.

What is the Bipolar Disorder Therapeutics market growth?

The global Bipolar Disorder Therapeutics market is expected to grow at a CAGR of 5.9% from 2026 to 2035 to reach $10.39 billion by 2035.

Who are the key players in Bipolar Disorder Therapeutics market?

Some Key Players in the Bipolar Disorder Therapeutics market Include, AbbVie Inc., Pfizer Inc., Astellas Pharma Inc., AstraZeneca PLC, Bristol-Myers Squibb, GlaxoSmithKline PLC, Janssen Pharmaceuticals, Novartis AG, Otsuka Pharmaceutical Co. Ltd., Eli

Major trend in this market includes: The Rise Of Novel Therapies For Bipolar Disorders. For further insights on this market. request a sample here

North America was the largest region in the bipolar disorder therapeutics market in 2025. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the bipolar disorder therapeutics market report are

Book your 30 minutes free consultation with our research experts

Contact Us